RLMD
Relmada Therapeutics Inc
3.70$
-2.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Relmada Therapeutics Inc (RLMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -9.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -10 | -13 | -13 | -17 | -8.8 | -18 | -6.4 | -6.7 | -15 | -15 | -9.6 | -46 | |
| 11 | 9.9 | 8.3 | 7.2 | 8.0 | 6.7 | 4.5 | 3.5 | 3.6 | 3.2 | 3.6 | -1.8 | 8.7 | |
| -1.7 | 5.4 | 0.6 | -2.6 | -2.5 | 2.9 | -4.8 | 0.0 | 4.7 | 1.2 | -0.2 | 0.9 | 6.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 3.9 | 7.7 | 10 | 14 | 16 | 11 | 15 | 6.7 | 6.8 | -77 | -135 | 18 | -188 | |
| 0.0 | -0.1 | 0.2 | 0.0 | -0.1 | -0.2 | 0.0 | -0.1 | 0.0 | 94 | 157 | -6.4 | 244 | |
| -7.8 | -2.6 | -2.8 | 0.8 | -0.6 | 2.4 | -2.7 | 0.2 | 0.0 | 2.1 | 6.3 | 1.6 | 10.0 | |
| -12 | -10 | -13 | -13 | -17 | -8.8 | -18 | -6.4 | -6.7 | -15 | -15 | -9.6 | -46 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.